Top Medical Stocks To Add to Your Watchlist - August 1st

Key Points

• MarketBeat identifies UnitedHealth Group, Eli Lilly and Company, and Novo Nordisk as key medical stocks to watch due to their high trading volumes.
• UnitedHealth Group's stock (UNH) recently traded at $239.33, reflecting a significant decline from its 12-month high of $630.73.
• Eli Lilly's shares (LLY) reached $759.22, with a high market capitalization of $719.54 billion and a notable PE ratio of 61.78.

UnitedHealth Group, Eli Lilly and Company, and Novo Nordisk A/S are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are equity shares in publicly traded companies that develop, manufacture or distribute healthcare products and services—ranging from pharmaceuticals and biotechnology to medical devices and healthcare providers. Investing in medical stocks lets shareholders participate in the growth and innovation of the healthcare sector, but also exposes them to risks such as regulatory changes, clinical trial outcomes and patent expirations. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

UNH stock traded down $10.23 during mid-day trading on Friday, reaching $239.33. 18,675,164 shares of the company's stock were exchanged, compared to its average volume of 11,842,054. The company has a market cap of $217.10 billion, a price-to-earnings ratio of 10.37, a price-to-earnings-growth ratio of 1.54 and a beta of 0.45. The stock's 50 day moving average is $298.02 and its 200 day moving average is $418.35. UnitedHealth Group has a 12-month low of $239.11 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

Read Our Latest Research Report on UNH

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of NYSE LLY traded up $19.15 during midday trading on Friday, hitting $759.22. The stock had a trading volume of 2,495,194 shares, compared to its average volume of 3,791,774. The company has a market capitalization of $719.54 billion, a PE ratio of 61.78, a P/E/G ratio of 1.08 and a beta of 0.40. The stock has a 50 day simple moving average of $774.56 and a 200-day simple moving average of $799.73. Eli Lilly and Company has a 1 year low of $677.09 and a 1 year high of $972.53. The company has a quick ratio of 1.06, a current ratio of 1.37 and a debt-to-equity ratio of 2.18.

Read Our Latest Research Report on LLY

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of NYSE:NVO traded up $1.01 during midday trading on Friday, hitting $48.08. The company had a trading volume of 23,591,977 shares, compared to its average volume of 10,655,308. Novo Nordisk A/S has a twelve month low of $46.90 and a twelve month high of $139.74. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.74 and a quick ratio of 0.56. The stock has a market cap of $214.67 billion, a price-to-earnings ratio of 14.22, a price-to-earnings-growth ratio of 0.97 and a beta of 0.64. The business's 50-day simple moving average is $69.64 and its 200-day simple moving average is $72.95.

Read Our Latest Research Report on NVO

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.